Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

1. WO2007148924 - UTILISATION D'OR COLLOÏDAL EN TANT QU'ADJUVANT

Numéro de publication WO/2007/148924
Date de publication 27.12.2007
N° de la demande internationale PCT/KR2007/003002
Date du dépôt international 21.06.2007
CIB
A61K 39/39 2006.01
ANÉCESSITÉS COURANTES DE LA VIE
61SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
KPRÉPARATIONS À USAGE MÉDICAL, DENTAIRE OU POUR LA TOILETTE
39Préparations médicinales contenant des antigènes ou des anticorps
39caractérisées par les additifs immunostimulants, p.ex. par les adjuvants chimiques
CPC
A61K 2039/55505
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
555characterised by a specific combination antigen/adjuvant
55505Inorganic adjuvants
A61K 39/39
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
39characterised by the immunostimulating additives, e.g. chemical adjuvants
A61K 47/643
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
50the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
51the non-active ingredient being a modifying agent
62the modifying agent being a protein, peptide or polyamino acid
64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
A61K 47/6923
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
50the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
69the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
6921the form being a particulate, a powder, an adsorbate, a bead or a sphere
6923the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
B82Y 5/00
BPERFORMING OPERATIONS; TRANSPORTING
82NANOTECHNOLOGY
YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
5Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Déposants
  • DOBEEL CO., LTD. [KR/KR]; 406~407, Byucksan Technopia I 434-6, Sangdaewon-dong Jungwon-gu, Seongnam-si Gyeonggi-do 462-716, KR (AllExceptUS)
  • YUM, Jung Sun [KR/KR]; KR (UsOnly)
  • AHN, Byung Cheol [KR/KR]; KR (UsOnly)
  • MOON, Hong Mo [KR/KR]; KR (UsOnly)
Inventeurs
  • YUM, Jung Sun; KR
  • AHN, Byung Cheol; KR
  • MOON, Hong Mo; KR
Mandataires
  • SON, Min; 19th Floor, City Air Tower 159-9 Samseong-dong, Gangnam-gu Seoul 135-973, KR
Données relatives à la priorité
10-2006-005704023.06.2006KR
Langue de publication anglais (EN)
Langue de dépôt coréen (KO)
États désignés
Titre
(EN) USE OF COLLOIDAL GOLD AS AN ADJUVANT
(FR) UTILISATION D'OR COLLOÏDAL EN TANT QU'ADJUVANT
Abrégé
(EN)
The present invention relates to an adjuvant composition comprising colloidal gold. The administration of the colloidal gold with an antigen significantly increases cell-mediated immunity, thereby being used as an effective adjuvant for a therapeutic vaccine.
(FR)
La présente invention concerne une composition d'adjuvant comprenant de l'or colloïdal. L'administration de l'or colloïdal avec un antigène permet d'augmenter de manière significative l'immunité induite par les cellules, constituant ainsi un adjuvant efficace pour un vaccin thérapeutique.
Dernières données bibliographiques dont dispose le Bureau international